In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose

被引：24
|
作者：
Chagla, Zain [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 03期
关键词：
D O I：
10.7326/ACPJ202103160-028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC28 / JC28
页数：1
相关论文
共 50 条
  • [1] In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose
    Chagla, Zain
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) : JC29 - JC29
  • [2] In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at ≥7 d after the second dose
    Granwehr, Bruno P.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : JC52 - JC52
  • [3] The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : JC124 - JC124
  • [4] The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
    Chagla, Zain
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (02) : JC15 - JC15
  • [5] The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (07) : JC75 - JC75
  • [6] Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine
    Girolami, Ilaria
    Eisendle, Klaus
    Kluge, Reinhard Walther
    Hanspeter, Esther
    Eccher, Albino
    Vizziello, Leonardo
    Zampieri, Pierfrancesco
    Mazzoleni, Guido
    PATHOLOGICA, 2022, 114 (04) : 322 - 325
  • [7] Covid-19: Most UK adults had antibodies after one dose of AstraZeneca or Pfizer vaccine, data suggest
    Iacobucci, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373 : n1274
  • [8] Suboptimal humoral immunological response to the 2nd dose of anti-COVID19 mRNA-1273 vaccine (Moderna) in kidney transplant patients
    Martin-Garcia, Jesus
    Carreno Cornejo, Gilda
    Manzanedo Bueno, Rosario
    Rosado Rubio, Consolacion
    Menendez Gonzalez, David
    Barreda Grande, Dolores
    Felipe Fernandez, Carmen
    NEFROLOGIA, 2023, 43 (03): : 380 - 382
  • [9] A Comparison of Strategies to Improve Uptake of COVID-19 Vaccine among High-Risk Adults in Nairobi, Kenya in 2022
    Yego, Joan
    Korom, Robert
    Eriksson, Emma
    Njavika, Sharon
    Sane, Oulimata
    Kanorio, Purity
    Rotich, Oliver
    Wambui, Stellah
    Mureithi, Eunice
    VACCINES, 2023, 11 (02)
  • [10] Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
    Santovito, Luca Spiro
    Pinna, Graziano
    INFLAMMATION RESEARCH, 2021, 70 (09) : 931 - 933
12345